Tim Oswald

Tim Oswald is an experienced professional in the pharmaceutical and healthcare industry, holding the position of Hematology Therapeutic Account Manager at Genentech since August 2025. Prior to this role, Tim served as Associate Director of Hematology Strategic Accounts and Hematology Therapy Specialist at ADC Therapeutics, where Tim successfully launched Zynlonta into the lymphoma market and developed key opinion leaders (KOLs). Tim's experience includes key account management in hematology/oncology rare diseases at EUSA Pharma, oncology sales at Eisai US, and senior oncology specialization at Amgen. Tim has also worked with Grifols and Bristol-Myers Squibb, achieving significant sales accomplishments and rankings. Tim's career began at Takeda Pharmaceuticals and Beneficial/Household Incorporated. Educational qualifications include a Bachelor of Science in Marketing from The Ohio State University and a Bachelor of Science in Business Administration from Youngstown State University.